Centessa Pharmaceuticals plc (CNTA)
NASDAQ·Healthcare·Biotechnology
$39.84
+0.21%
Mkt Cap $3.51B
Analyst Ratings
No recent rating data.
Price Target (16 analysts)
$38.60
Range $35.00 – $42.00
Implied Upside
-3.1%
Consensus $38.60 vs current $39.84
NASDAQ·Healthcare·Biotechnology
$39.84
+0.21%
Mkt Cap $3.51B
No recent rating data.
Price Target (16 analysts)
$38.60
Range $35.00 – $42.00
-3.1%
Consensus $38.60 vs current $39.84